ORION Biotech Intelligence

Drug / Company Analysis
Refresh status: checking
ClinicalTrials.gov · AI
Connector: Checking
Data: Checking
Loading research workspace

Resolving the route and available access…

ORION / RESEARCH OBSERVATORY

Your next discovery.
Connected to evidence.

Pick up the thread. Review what changed, reopen a saved brief, or investigate the next question.

01 / Research02 / Preserve03 / RevisitExplore the methodology ↗
CONTINUE YOUR WORK

Your recent briefs

Your saved research will appear after your account is verified.

FOR INDEPENDENT BIOTECH RESEARCHERS

Keep biotech research connected to its evidence.

Turn fragmented public biotech records into reviewable, saved, source-linked briefs. Search one company, drug, or indication and preserve the evidence trail for later review.

ORION is a facts-only research workspace. It does not provide buy or sell recommendations, target prices, rankings, expected returns, or personalized advice.
Sign in to start a research trail Explore a sample brief

NO CARD REQUIRED · NO PRICE TARGETS · SOURCE-LINKED EVIDENCE · UNRESOLVED CLAIMS STAY VISIBLE

THE RESEARCH PROBLEM

The work is not one search. It is keeping the research current.

Independent biotech research means reopening the same trial records, FDA pages, filings, company releases, and notes. ORION turns that repeated work into a research record you can return to.

BEFORE

Rebuild the context

Reopen registry, FDA, SEC, issuer, and scientific-source tabs. Reconstruct which claim came from where and compare old notes manually.

WITH ORION

Return to the record

Keep entity identity, original links, retrieval context, source states, and unresolved questions attached to the saved brief.

GENERAL AI

Useful for the question in front of you

  • Starts from the current prompt
  • Produces another answer or summary
  • Leaves you to compare past answers
ORION

Built for research continuity

  • Starts from your saved companies and assets
  • Preserves source links and verification states
  • Shows what changed since the last review
THE ORION LOOP

Search → verify → save → monitor

  1. 01SearchCompany, drug, ticker, indication, or trial
  2. 02VerifyReview source identity, state, and gaps
  3. 03SaveKeep a brief you can reopen and share
  4. 04MonitorReturn to new and changed evidence
WATCHLISTKeep the entities you repeatedly research.
EVIDENCE TIMELINEReview dated records with original source links.
WHAT CHANGEDSeparate new, updated, and unresolved evidence.
SAVED BRIEFSContinue the research without rebuilding context.

General AI is optimized for the current question. ORION is optimized for continuity across the biotech entities you repeatedly research.

Daily Radar · source-verified research queue
VERIFIED RESEARCH QUEUE

Daily Radar

At most three source-verifiable targets. Empty days remain empty.

COMPANY OR DRUG RESEARCH

Start a new analysis

Build an evidence-linked brief for a company, drug, or indication.

  1. 1Enter a name
  2. 2Review evidence
  3. 3Export or share
Enter to create a brief · ClinicalTrials.gov + regulatory sources + ORION evidence synthesis
QUICK:
PRIMARY
ClinicalTrials.gov
CURATED
FDA Coverage
MIXED
Source Freshness
REVIEW THE REAL PRODUCT

Inspect the evidence structure, methods, and boundaries before you rely on the output.

ORION publishes the materials an independent researcher needs to evaluate the workflow — not just a feature list.

OUTPUTSample ReportReview Entity Passport, claim-level evidence, and unresolved fields before creating an account. METHODMethodologySee how identity, sources, conflicts, synthesis, and missing data are handled. TRUSTTrust CenterInspect capability state, system reliability, evidence quality, and public limitations. BOUNDARYCoverage BoundariesKnow which sources are connected, curated, query-dependent, or not available. DAILY SITREPDaily SITREPReview confirmed changes, unresolved source gaps, and the next 24–72 hours. PUBLIC INDEXRare Disease ReportsSearch only reports where a rare disease was explicitly identified. FIRST SESSIONGetting StartedAnalyze one name, verify identity, review gaps, save the result, and revisit it. SELF-SERVEStarter · $29/monthReview the focused individual plan, live capability state, and launch boundary.
STARTER · $29 / MONTH

Keep a focused biotech research list current

Starter is not a fee for one more AI answer. It maintains the watchlist, source-linked briefs, change history, and unresolved evidence you return to throughout the month.

  • 10 monitored companies
  • 20 monitored pipelines / trials
  • 30 source-linked reports / month
  • Full change history & source links
Review Starter · $29/month View a sample report
QUESTIONS, ANSWERED DIRECTLY

Know what ORION does — and what it does not do.

Is ORION an investment recommendation service?

No. ORION organizes public biotech evidence and monitors changes. It does not recommend buying or selling securities.

How is this different from ChatGPT, Perplexity, or Claude?

General AI answers the current question. ORION preserves your watchlist, evidence history, source states, saved briefs, and changes over time.

What happens when evidence is missing?

The value remains unavailable or unresolved. ORION does not replace missing evidence with a fabricated value or score.

What does Starter include?

Starter includes monitoring for 10 companies and 20 pipelines or trials, 30 source-linked reports per month, change history, source links, and available exports.

Does ORION calculate scores or approval probabilities?

No. ORION does not calculate investment scores, rankings, approval probabilities, target prices, or expected returns.

Which sources does ORION use?

Supported workflows include ClinicalTrials.gov, FDA and regulatory records, SEC filings, issuer disclosures, public scientific records, and available market records.

Does ORION cover every biotech source?

No. Coverage is not globally exhaustive. Source availability and therapeutic-area boundaries remain public and reviewable.

Is annual billing available?

No. Starter is currently offered with monthly billing only.

What is the difference between a saved report and refreshed research?

A saved report preserves a point-in-time result. Refresh requests new source retrieval and does not guarantee that every external source will be available.

Can I inspect an example first?

Yes. The public sample demonstrates the evidence structure without presenting customer data, a live full report, or comprehensive coverage.

START WITH ONE NAME

Build a research trail for a company or drug you already follow.

ORION shows the public record; the interpretation remains yours.

Daily Radar
A daily queue of no more than three source-verified public records. Empty days remain empty.
Checking market sources
Checking available market records
Local research tools
YOUR RESEARCH / MISSION OVERVIEW
One place to pick up the thread.

Return to saved evidence. Inspect source changes. Build on the work you have already done.

SAVED IN YOUR ACCOUNT

Continue a recent brief

Your saved research will appear after your account is verified.

Key catalyst timeline

Watchlist changes

Evidence review status

Evidence sources and freshness

Biotech companies by recorded market value

Catalyst Radar

Track clinical readouts, FDA dates, scientific meetings, disclosures, and patent or regulatory events from their sources.

Evidence Review

Review evidence states, downside uncertainties, and missing data. ORION does not recommend buying or selling any security.

Checking the FDA calendar
Checking source coverage

What claim should ORION verify?

Split a regulatory or scientific claim into independently auditable subclaims.

Loading your saved briefings
Alerts
PDUFA dates, clinical trial status changes, and source-recorded updates — rule-based and disclosed for each company on your watchlist.
Watchlist change delivery
Send source-recorded trial, FDA, and competitor changes to your verified account email. Slack remains unavailable unless the backend explicitly enables controlled delivery.
Delivery contains observed previous and new values with source links. No score, recommendation, or future prediction is added.
Asset Workbench
Source-recorded competitive pipelines and explicit, user-supplied investment-assumption inputs. ORION never inserts hidden valuation defaults.
Coming Soon. This capability is designed but is not currently available. No live output is implied.
Watchlist Evidence Workspace
Monitor public company records without providing holdings, purchase prices, wealth, or risk-tolerance information.
Organization & Audit
Server-enforced seats, roles, invitations, workspaces, and an append-only administrative audit log.
Indication / Target Landscape
Find ClinicalTrials.gov industry sponsors and connect them to your completed ORION reports without hiding unscorable companies.

Competitive landscape search

Registry relationships are evidence of trial participation, not proof of asset ownership.

COMING SOON
Enter an indication or target to search the live registry.
SOURCE CHANGE OBSERVATORY
Keep the evidence in view.
Review your active monitoring state and source-recorded changes. Each record shows its own date and coverage. Change monitoring requires Starter access; live checkout is currently unavailable.
Saved research comparisons

Historical differences between saved research snapshots. A newly included or absent record can reflect retrieval scope; it does not establish that a trial started, ended, or was removed from its original registry.

Advanced sources · Form 4, 13F, FINRA, patents
SEC Form 4 insider transactions
Reported officer and director transactions from SEC EDGAR ownership filings. Transaction codes and values are shown as filed without interpretation.
Past and current source records only. This is historical data. It does not predict or guarantee future performance.
Research preferences
Each preference is stored independently on this device.